We use an extensive set of criteria, including scientific rationale and medical need, to determine which projects to move from discovery research into development. Our clinical scientists and medical professionals then perform the essential role of translating basic science into patient benefit. They help determine which potential new drugs are tested against specific diseases in the clinic and guide chosen drug candidates through the many phases of clinical testing.

Combining Roche and Genentech has created one of the strongest R&D pipelines in the industry. View the combined Roche Group (PDF) development pipeline. For additional information, please see the Roche Pharmaceuticals Pipeline.

Genentech Research and Early Development operates as an independent center within the Roche Group and currently has over 15 new molecular entities in clinical development. View Genentech's early-stage (PDF) development pipeline. For additional information, please see the Genentech Pipeline.